154 related articles for article (PubMed ID: 36175778)
21. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
Turner N; Pearson A; Sharpe R; Lambros M; Geyer F; Lopez-Garcia MA; Natrajan R; Marchio C; Iorns E; Mackay A; Gillett C; Grigoriadis A; Tutt A; Reis-Filho JS; Ashworth A
Cancer Res; 2010 Mar; 70(5):2085-94. PubMed ID: 20179196
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway.
Lu Y; Liu Y; Oeck S; Zhang GJ; Schramm A; Glazer PM
Cancer Res; 2020 Nov; 80(21):4655-4667. PubMed ID: 32873635
[TBL] [Abstract][Full Text] [Related]
23. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
24. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.
Alam M; Ahmad R; Rajabi H; Kharbanda A; Kufe D
J Biol Chem; 2013 Oct; 288(43):30892-903. PubMed ID: 24043631
[TBL] [Abstract][Full Text] [Related]
25. UCP1 regulates ALDH-positive breast cancer stem cells through releasing the suppression of Snail on FBP1.
Zhang F; Liu B; Deng Q; Sheng D; Xu J; He X; Zhang L; Liu S
Cell Biol Toxicol; 2021 Apr; 37(2):277-291. PubMed ID: 32472219
[TBL] [Abstract][Full Text] [Related]
26. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603
[TBL] [Abstract][Full Text] [Related]
27. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.
Ciccarelli C; Vulcano F; Milazzo L; Gravina GL; Marampon F; Macioce G; Giampaolo A; Tombolini V; Di Paolo V; Hassan HJ; Zani BM
Mol Cancer; 2016 Feb; 15():16. PubMed ID: 26897742
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.
Debeb BG; Lacerda L; Xu W; Larson R; Solley T; Atkinson R; Sulman EP; Ueno NT; Krishnamurthy S; Reuben JM; Buchholz TA; Woodward WA
Stem Cells; 2012 Nov; 30(11):2366-77. PubMed ID: 22961641
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
[TBL] [Abstract][Full Text] [Related]
30. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
31. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
32. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
[TBL] [Abstract][Full Text] [Related]
33. Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: Colocalization of ALDH and CD44.
Kuo YC; Wang LJ; Rajesh R
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():362-372. PubMed ID: 31147008
[TBL] [Abstract][Full Text] [Related]
34. Breast Cancer Stem Cells-derived Extracellular Vesicles Affect PPARG Expression by Delivering MicroRNA-197 in Breast Cancer Cells.
Li L; Xiong Y; Wang N; Zhu M; Gu Y
Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
[TBL] [Abstract][Full Text] [Related]
35. Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells.
Suman S; Das TP; Damodaran C
Br J Cancer; 2013 Nov; 109(10):2587-96. PubMed ID: 24129237
[TBL] [Abstract][Full Text] [Related]
36. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y
Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923
[TBL] [Abstract][Full Text] [Related]
37. Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B.
Li X; Chen W; Huang L; Zhu M; Zhang H; Si Y; Li H; Luo Q; Yu B
Pharmacol Res; 2022 May; 179():106222. PubMed ID: 35413424
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.
Tomlinson DC; Lamont FR; Shnyder SD; Knowles MA
Cancer Res; 2009 Jun; 69(11):4613-20. PubMed ID: 19458078
[TBL] [Abstract][Full Text] [Related]
39. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
40. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
Hu Y; Mintz A; Shah SR; Quinones-Hinojosa A; Hsu W
Carcinogenesis; 2014 Jul; 35(7):1491-9. PubMed ID: 24445144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]